Qualtec Co

Qualtec Co R&D Expenses

The Research & Development Expenses of Qualtec Co (9165.T) as of Oct 20, 2026 is 179.10 M JPY. In the previous year, Research & Development Expenses was 87.73 M JPY — a change of 104.15% (higher).

R&D Expenses

179.10 MJPY

YoY

104.15%

Last updated:

Research & Development Expenses of Qualtec Co is 2025 179.10 M JPY. Research & Development Expenses of Qualtec Co was 2024 87.73 M JPY. It decreases by 104.15% higher compared to the previous year.

The Qualtec Co R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2021
72.54 M JPY
Jan 1, 2022
89.86 M JPY
Jan 1, 2023
83.64 M JPY
Jan 1, 2024
87.73 M JPY
Jan 1, 2025
179.10 M JPY
The Qualtec Co R&D Expenses history
YEARR&D ExpensesYoY
179.10 MJPY+104.15%
87.73 MJPY+4.89%
83.64 MJPY-6.93%
89.86 MJPY+23.88%
72.54 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Qualtec Co Stock analysis

What does Qualtec Co do? Qualtec Co Ltd generates revenue through three business segments. The Reliability Evaluation Business segment sells testing machines and provides environmental, electrical, and vibration tests, including non-defective and defective product analysis. The Microfabrication Business segment offers laser processing services for build-up boards and flexible printed boards in both prototype and mass production. The Other Business segment delivers genetic mutation detection services for pets, contracted biomedical testing for packaging materials and syringes, and zero innovation consulting services. These services target industrial clients, veterinary clinics, and biomedical companies. The company's Reliability Evaluation segment serves manufacturers requiring product reliability validation. The Microfabrication segment caters to electronics manufacturers needing laser processing for circuit boards. The genetic testing services in the Other Business segment are sold to pet owners and veterinary clinics. Biomedical testing services target companies in the medical device industry. Zero innovation consulting is offered to businesses seeking technology and surface treatment solutions. Qualtec's product portfolio includes testing machines, laser processing services, genetic mutation detection, biomedical testing, and consulting services. The company's primary customers are electronics manufacturers, biomedical firms, veterinary clinics, and pet owners. These segments collectively serve industrial and healthcare markets with specialized technical services. Qualtec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Qualtec Co stock

Research & Development Expenses of Qualtec Co is 179.10 M JPY in 2025.

Research & Development Expenses of Qualtec Co changed from 87.73 M JPY to 179.10 M JPY, representing a 104.15% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Qualtec Co since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Qualtec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Qualtec Co

All Key Metrics — Qualtec Co